APO Research
Talk to an analyst

APO RESEARCH · REPORT

Mercaptopurine Tablets

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Mercaptopurine Tablets Industry Growth and Trends Forecast to 2032

23 December 2025102 pages

Choose your research edition.

Industry ResearchMercaptopurine Tablets Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Mercaptopurine Tablets Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Mercaptopurine Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mercaptopurine Tablets Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Mercaptopurine Tablets Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Mercaptopurine Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Mercaptopurine Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Mercaptopurine Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Mercaptopurine Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Mercaptopurine Tablets include Zhejiang Zhebei Pharmaceutical, Sinopharm, Shaanxi Hantang Pharmaceutical, China Resources Double-Crane Pharmaceutical, Zhejiang Hisun Pharmaceutical, Guangzhou Baiyunshan Guanghua Pharmaceutical, Viatris, Stason Pharmaceuticals and Hikma Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Mercaptopurine Tablets market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Mercaptopurine Tablets market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Mercaptopurine Tablets market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Mercaptopurine Tablets.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Mercaptopurine Tablets market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Mercaptopurine Tablets Market by Company

Zhejiang Zhebei Pharmaceutical

Sinopharm

Shaanxi Hantang Pharmaceutical

China Resources Double-Crane Pharmaceutical

Zhejiang Hisun Pharmaceutical

Guangzhou Baiyunshan Guanghua Pharmaceutical

Viatris

Stason Pharmaceuticals

Hikma Pharmaceuticals

Dr. Reddy's Laboratories

Mercaptopurine Tablets Segment by Type

25mg

50mg

Mercaptopurine Tablets Segment by Application

Hospital

Clinic

Others

Mercaptopurine Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mercaptopurine Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mercaptopurine Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mercaptopurine Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Mercaptopurine Tablets manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Mercaptopurine Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 25mg Table 2. Major Company of 50mg Table 3. Global Mercaptopurine Tablets Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Mercaptopurine Tablets Sales by Type (2021-2026) & (k units) Table 5. Global Mercaptopurine Tablets Sales Market Share in Volume by Type (2021-2026) Table 6. Global Mercaptopurine Tablets Sales by Type (2021-2026) & (US$ Million) Table 7. Global Mercaptopurine Tablets Sales Market Share in Value by Type (2021-2026) Table 8. Global Mercaptopurine Tablets Price by Type (2021-2026) & (USD/unit) Table 9. Global Mercaptopurine Tablets Sales by Type (2027-2032) & (k units) Table 10. Global Mercaptopurine Tablets Sales Market Share in Volume by Type (2027-2032) Table 11. Global Mercaptopurine Tablets Sales by Type (2027-2032) & (US$ Million) Table 12. Global Mercaptopurine Tablets Sales Market Share in Value by Type (2027-2032) Table 13. Global Mercaptopurine Tablets Price by Type (2027-2032) & (USD/unit) Table 14. North America Mercaptopurine Tablets Sales by Type (2021-2026) & (k units) Table 15. North America Mercaptopurine Tablets Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Mercaptopurine Tablets Sales by Type (2021-2026) & (k units) Table 17. Europe Mercaptopurine Tablets Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Mercaptopurine Tablets Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Mercaptopurine Tablets Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Mercaptopurine Tablets Sales by Type (2021-2026) & (k units) Table 21. Latin America Mercaptopurine Tablets Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Mercaptopurine Tablets Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Mercaptopurine Tablets Sales by Type (2021-2026) & (US$ Million) Table 24. Mercaptopurine Tablets Industry Trends Table 25. Mercaptopurine Tablets Industry Drivers Table 26. Mercaptopurine Tablets Industry Opportunities and Challenges Table 27. Mercaptopurine Tablets Industry Restraints Table 28. Global Mercaptopurine Tablets Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Mercaptopurine Tablets Revenue Market Share by Company (2021-2026) Table 30. Global Mercaptopurine Tablets Sales by Company (2021-2026) & (k units) Table 31. Global Mercaptopurine Tablets Sales Share by Company (2021-2026) Table 32. Global Mercaptopurine Tablets Market Price by Company (2021-2026) & (USD/unit) Table 33. Global Mercaptopurine Tablets Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Mercaptopurine Tablets Major Company Production Sites and Headquarters Table 35. Global Mercaptopurine Tablets Company, Product Type & Application Table 36. Global Mercaptopurine Tablets Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Mercaptopurine Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Mercaptopurine Tablets Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Mercaptopurine Tablets Sales by Region (2021-2026) & (k units) Table 41. Global Mercaptopurine Tablets Sales Market Share in Volume by Region (2021-2026) Table 42. Global Mercaptopurine Tablets Sales by Region (2021-2026) & (US$ Million) Table 43. Global Mercaptopurine Tablets Sales Market Share in Value by Region (2021-2026) Table 44. Global Mercaptopurine Tablets Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 45. Global Mercaptopurine Tablets Sales by Region (2027-2032) & (k units) Table 46. Global Mercaptopurine Tablets Sales Market Share in Volume by Region (2027-2032) Table 47. Global Mercaptopurine Tablets Sales by Region (2027-2032) & (US$ Million) Table 48. Global Mercaptopurine Tablets Sales Market Share in Value by Region (2027-2032) Table 49. Global Mercaptopurine Tablets Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2027-2032) Table 50. Global Mercaptopurine Tablets Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Mercaptopurine Tablets Sales by Application (2021-2026) & (k units) Table 52. Global Mercaptopurine Tablets Sales Market Share in Volume by Application (2021-2026) Table 53. Global Mercaptopurine Tablets Sales by Application (2021-2026) & (US$ Million) Table 54. Global Mercaptopurine Tablets Sales Market Share in Value by Application (2021-2026) Table 55. Global Mercaptopurine Tablets Price by Application (2021-2026) & (USD/unit) Table 56. Global Mercaptopurine Tablets Sales by Application (2027-2032) & (k units) Table 57. Global Mercaptopurine Tablets Sales Market Share in Volume by Application (2027-2032) Table 58. Global Mercaptopurine Tablets Sales by Application (2027-2032) & (US$ Million) Table 59. Global Mercaptopurine Tablets Sales Market Share in Value by Application (2027-2032) Table 60. Global Mercaptopurine Tablets Price by Application (2027-2032) & (USD/unit) Table 61. North America Mercaptopurine Tablets Sales by Application (2021-2026) & (k units) Table 62. North America Mercaptopurine Tablets Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Mercaptopurine Tablets Sales by Application (2021-2026) & (k units) Table 64. Europe Mercaptopurine Tablets Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Mercaptopurine Tablets Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Mercaptopurine Tablets Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Mercaptopurine Tablets Sales by Application (2021-2026) & (k units) Table 68. Latin America Mercaptopurine Tablets Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Mercaptopurine Tablets Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Mercaptopurine Tablets Sales by Application (2021-2026) & (US$ Million) Table 71. Zhejiang Zhebei Pharmaceutical Company Information Table 72. Zhejiang Zhebei Pharmaceutical Business Overview Table 73. Zhejiang Zhebei Pharmaceutical Mercaptopurine Tablets Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 74. Zhejiang Zhebei Pharmaceutical Mercaptopurine Tablets Product Portfolio Table 75. Zhejiang Zhebei Pharmaceutical Recent Development Table 76. Sinopharm Company Information Table 77. Sinopharm Business Overview Table 78. Sinopharm Mercaptopurine Tablets Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 79. Sinopharm Mercaptopurine Tablets Product Portfolio Table 80. Sinopharm Recent Development Table 81. Shaanxi Hantang Pharmaceutical Company Information Table 82. Shaanxi Hantang Pharmaceutical Business Overview Table 83. Shaanxi Hantang Pharmaceutical Mercaptopurine Tablets Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 84. Shaanxi Hantang Pharmaceutical Mercaptopurine Tablets Product Portfolio Table 85. Shaanxi Hantang Pharmaceutical Recent Development Table 86. China Resources Double-Crane Pharmaceutical Company Information Table 87. China Resources Double-Crane Pharmaceutical Business Overview Table 88. China Resources Double-Crane Pharmaceutical Mercaptopurine Tablets Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. China Resources Double-Crane Pharmaceutical Mercaptopurine Tablets Product Portfolio Table 90. China Resources Double-Crane Pharmaceutical Recent Development Table 91. Zhejiang Hisun Pharmaceutical Company Information Table 92. Zhejiang Hisun Pharmaceutical Business Overview Table 93. Zhejiang Hisun Pharmaceutical Mercaptopurine Tablets Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Zhejiang Hisun Pharmaceutical Mercaptopurine Tablets Product Portfolio Table 95. Zhejiang Hisun Pharmaceutical Recent Development Table 96. Guangzhou Baiyunshan Guanghua Pharmaceutical Company Information Table 97. Guangzhou Baiyunshan Guanghua Pharmaceutical Business Overview Table 98. Guangzhou Baiyunshan Guanghua Pharmaceutical Mercaptopurine Tablets Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Guangzhou Baiyunshan Guanghua Pharmaceutical Mercaptopurine Tablets Product Portfolio Table 100. Guangzhou Baiyunshan Guanghua Pharmaceutical Recent Development Table 101. Viatris Company Information Table 102. Viatris Business Overview Table 103. Viatris Mercaptopurine Tablets Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Viatris Mercaptopurine Tablets Product Portfolio Table 105. Viatris Recent Development Table 106. Stason Pharmaceuticals Company Information Table 107. Stason Pharmaceuticals Business Overview Table 108. Stason Pharmaceuticals Mercaptopurine Tablets Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Stason Pharmaceuticals Mercaptopurine Tablets Product Portfolio Table 110. Stason Pharmaceuticals Recent Development Table 111. Hikma Pharmaceuticals Company Information Table 112. Hikma Pharmaceuticals Business Overview Table 113. Hikma Pharmaceuticals Mercaptopurine Tablets Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Hikma Pharmaceuticals Mercaptopurine Tablets Product Portfolio Table 115. Hikma Pharmaceuticals Recent Development Table 116. Dr. Reddy's Laboratories Company Information Table 117. Dr. Reddy's Laboratories Business Overview Table 118. Dr. Reddy's Laboratories Mercaptopurine Tablets Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Dr. Reddy's Laboratories Mercaptopurine Tablets Product Portfolio Table 120. Dr. Reddy's Laboratories Recent Development Table 121. North America Mercaptopurine Tablets Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 122. North America Mercaptopurine Tablets Sales by Country (2021-2026) & (k units) Table 123. North America Mercaptopurine Tablets Sales Market Share by Country (2021-2026) Table 124. North America Mercaptopurine Tablets Sales Forecast by Country (2027-2032) & (k units) Table 125. North America Mercaptopurine Tablets Sales Market Share Forecast by Country (2027-2032) Table 126. North America Mercaptopurine Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. North America Mercaptopurine Tablets Market Size by Country (2021-2026) & (US$ Million) Table 128. North America Mercaptopurine Tablets Market Share by Country (2021-2026) Table 129. North America Mercaptopurine Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. North America Mercaptopurine Tablets Market Share Forecast by Country (2027-2032) Table 131. Europe Mercaptopurine Tablets Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 132. Europe Mercaptopurine Tablets Sales by Country (2021-2026) & (k units) Table 133. Europe Mercaptopurine Tablets Sales Market Share by Country (2021-2026) Table 134. Europe Mercaptopurine Tablets Sales Forecast by Country (2027-2032) & (k units) Table 135. Europe Mercaptopurine Tablets Sales Market Share Forecast by Country (2027-2032) Table 136. Europe Mercaptopurine Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Europe Mercaptopurine Tablets Market Size by Country (2021-2026) & (US$ Million) Table 138. Europe Mercaptopurine Tablets Market Share by Country (2021-2026) Table 139. Europe Mercaptopurine Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Europe Mercaptopurine Tablets Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Mercaptopurine Tablets Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Mercaptopurine Tablets Sales by Country (2021-2026) & (k units) Table 143. Asia-Pacific Mercaptopurine Tablets Sales Market Share by Country (2021-2026) Table 144. Asia-Pacific Mercaptopurine Tablets Sales Forecast by Country (2027-2032) & (k units) Table 145. Asia-Pacific Mercaptopurine Tablets Sales Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Mercaptopurine Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Mercaptopurine Tablets Market Size by Country (2021-2026) & (US$ Million) Table 148. Asia-Pacific Mercaptopurine Tablets Market Share by Country (2021-2026) Table 149. Asia-Pacific Mercaptopurine Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Asia-Pacific Mercaptopurine Tablets Market Share Forecast by Country (2027-2032) Table 151. Latin America Mercaptopurine Tablets Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 152. Latin America Mercaptopurine Tablets Sales by Country (2021-2026) & (k units) Table 153. Latin America Mercaptopurine Tablets Sales Market Share by Country (2021-2026) Table 154. Latin America Mercaptopurine Tablets Sales Forecast by Country (2027-2032) & (k units) Table 155. Latin America Mercaptopurine Tablets Sales Market Share Forecast by Country (2027-2032) Table 156. Latin America Mercaptopurine Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Latin America Mercaptopurine Tablets Market Size by Country (2021-2026) & (US$ Million) Table 158. Latin America Mercaptopurine Tablets Market Share by Country (2021-2026) Table 159. Latin America Mercaptopurine Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Latin America Mercaptopurine Tablets Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Mercaptopurine Tablets Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Mercaptopurine Tablets Sales by Country (2021-2026) & (k units) Table 163. Middle East and Africa Mercaptopurine Tablets Sales Market Share by Country (2021-2026) Table 164. Middle East and Africa Mercaptopurine Tablets Sales Forecast by Country (2027-2032) & (k units) Table 165. Middle East and Africa Mercaptopurine Tablets Sales Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Mercaptopurine Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Mercaptopurine Tablets Market Size by Country (2021-2026) & (US$ Million) Table 168. Middle East and Africa Mercaptopurine Tablets Market Share by Country (2021-2026) Table 169. Middle East and Africa Mercaptopurine Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Middle East and Africa Mercaptopurine Tablets Market Share Forecast by Country (2027-2032) Table 171. Key Raw Materials Table 172. Raw Materials Key Suppliers Table 173. Mercaptopurine Tablets Distributors List Table 174. Mercaptopurine Tablets Customers List Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. Mercaptopurine Tablets Image Figure 2. Global Mercaptopurine Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Mercaptopurine Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Mercaptopurine Tablets Sales (2021-2032) & (k units) Figure 5. 25mg Image Figure 6. Global 25mg Sales YoY Growth (2021-2032) & (k units) Figure 7. 50mg Image Figure 8. Global 50mg Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Mercaptopurine Tablets Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Mercaptopurine Tablets Market Share by Type 2025 VS 2032 Figure 11. North America Mercaptopurine Tablets Sales Market Share in Volume by Type in 2025 Figure 12. North America Mercaptopurine Tablets Sales Market Share in Value by Type in 2025 Figure 13. Europe Mercaptopurine Tablets Sales Market Share in Volume by Type in 2025 Figure 14. Europe Mercaptopurine Tablets Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Mercaptopurine Tablets Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Mercaptopurine Tablets Sales Market Share in Value by Type in 2025 Figure 17. Latin America Mercaptopurine Tablets Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Mercaptopurine Tablets Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Mercaptopurine Tablets Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Mercaptopurine Tablets Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Mercaptopurine Tablets Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (k units) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (k units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 29. Global Mercaptopurine Tablets Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Mercaptopurine Tablets Market Share by Application 2025 VS 2032 Figure 31. North America Mercaptopurine Tablets Sales Market Share in Volume by Application in 2025 Figure 32. North America Mercaptopurine Tablets Sales Market Share in Value by Application in 2025 Figure 33. Europe Mercaptopurine Tablets Sales Market Share in Volume by Application in 2025 Figure 34. Europe Mercaptopurine Tablets Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Mercaptopurine Tablets Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Mercaptopurine Tablets Sales Market Share in Value by Application in 2025 Figure 37. Latin America Mercaptopurine Tablets Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Mercaptopurine Tablets Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Mercaptopurine Tablets Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Mercaptopurine Tablets Sales Market Share in Value by Application in 2025 Figure 41. North America Mercaptopurine Tablets Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 42. North America Mercaptopurine Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Mercaptopurine Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Mercaptopurine Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Mercaptopurine Tablets Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. Europe Mercaptopurine Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Mercaptopurine Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Mercaptopurine Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Mercaptopurine Tablets Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Asia-Pacific Mercaptopurine Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Mercaptopurine Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Mercaptopurine Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Mercaptopurine Tablets Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Latin America Mercaptopurine Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Mercaptopurine Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Mercaptopurine Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Mercaptopurine Tablets Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Middle East and Africa Mercaptopurine Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Mercaptopurine Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Mercaptopurine Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Mercaptopurine Tablets Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Mercaptopurine Tablets Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 25mg
  • 50mg
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Zhejiang Zhebei Pharmaceutical
  • Sinopharm
  • Shaanxi Hantang Pharmaceutical
  • China Resources Double-Crane Pharmaceutical
  • Zhejiang Hisun Pharmaceutical
  • Guangzhou Baiyunshan Guanghua Pharmaceutical
  • Viatris
  • Stason Pharmaceuticals
  • Hikma Pharmaceuticals
  • Dr. Reddy's Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Mercaptopurine Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Mercaptopurine Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Mercaptopurine Tablets Market by Type
  6. 1.3.1 25mg
  7. 1.3.2 50mg
  8. 1.4 Global Mercaptopurine Tablets Market Size by Type
  9. 1.4.1 Global Mercaptopurine Tablets Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Mercaptopurine Tablets Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Mercaptopurine Tablets Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Mercaptopurine Tablets Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Mercaptopurine Tablets Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Mercaptopurine Tablets Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Mercaptopurine Tablets Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Mercaptopurine Tablets Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Mercaptopurine Tablets Industry Trends
  2. 2.2 Mercaptopurine Tablets Industry Drivers
  3. 2.3 Mercaptopurine Tablets Industry Opportunities and Challenges
  4. 2.4 Mercaptopurine Tablets Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Mercaptopurine Tablets Revenue (2021-2026)
  2. 3.2 Global Top Players by Mercaptopurine Tablets Sales (2021-2026)
  3. 3.3 Global Top Players by Mercaptopurine Tablets Price (2021-2026)
  4. 3.4 Global Mercaptopurine Tablets Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Mercaptopurine Tablets Major Company Production Sites & Headquarters
  6. 3.6 Global Mercaptopurine Tablets Company, Product Type & Application
  7. 3.7 Global Mercaptopurine Tablets Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Mercaptopurine Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Mercaptopurine Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Mercaptopurine Tablets Tier 1, Tier 2, and Tier 3
4 Mercaptopurine Tablets Regional Status and Outlook
  1. 4.1 Global Mercaptopurine Tablets Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Mercaptopurine Tablets Historic Market Size by Region
  3. 4.2.1 Global Mercaptopurine Tablets Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Mercaptopurine Tablets Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Mercaptopurine Tablets Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Mercaptopurine Tablets Forecasted Market Size by Region
  7. 4.3.1 Global Mercaptopurine Tablets Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Mercaptopurine Tablets Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Mercaptopurine Tablets Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Mercaptopurine Tablets by Application
  1. 5.1 Mercaptopurine Tablets Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Mercaptopurine Tablets Market Size by Application
  6. 5.2.1 Global Mercaptopurine Tablets Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Mercaptopurine Tablets Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Mercaptopurine Tablets Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Mercaptopurine Tablets Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Mercaptopurine Tablets Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Mercaptopurine Tablets Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Mercaptopurine Tablets Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Mercaptopurine Tablets Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Zhejiang Zhebei Pharmaceutical
  2. 6.1.1 Zhejiang Zhebei Pharmaceutical Company Information
  3. 6.1.2 Zhejiang Zhebei Pharmaceutical Business Overview
  4. 6.1.3 Zhejiang Zhebei Pharmaceutical Mercaptopurine Tablets Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Zhejiang Zhebei Pharmaceutical Mercaptopurine Tablets Product Portfolio
  6. 6.1.5 Zhejiang Zhebei Pharmaceutical Recent Developments
  7. 6.2 Sinopharm
  8. 6.2.1 Sinopharm Company Information
  9. 6.2.2 Sinopharm Business Overview
  10. 6.2.3 Sinopharm Mercaptopurine Tablets Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sinopharm Mercaptopurine Tablets Product Portfolio
  12. 6.2.5 Sinopharm Recent Developments
  13. 6.3 Shaanxi Hantang Pharmaceutical
  14. 6.3.1 Shaanxi Hantang Pharmaceutical Company Information
  15. 6.3.2 Shaanxi Hantang Pharmaceutical Business Overview
  16. 6.3.3 Shaanxi Hantang Pharmaceutical Mercaptopurine Tablets Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Shaanxi Hantang Pharmaceutical Mercaptopurine Tablets Product Portfolio
  18. 6.3.5 Shaanxi Hantang Pharmaceutical Recent Developments
  19. 6.4 China Resources Double-Crane Pharmaceutical
  20. 6.4.1 China Resources Double-Crane Pharmaceutical Company Information
  21. 6.4.2 China Resources Double-Crane Pharmaceutical Business Overview
  22. 6.4.3 China Resources Double-Crane Pharmaceutical Mercaptopurine Tablets Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 China Resources Double-Crane Pharmaceutical Mercaptopurine Tablets Product Portfolio
  24. 6.4.5 China Resources Double-Crane Pharmaceutical Recent Developments
  25. 6.5 Zhejiang Hisun Pharmaceutical
  26. 6.5.1 Zhejiang Hisun Pharmaceutical Company Information
  27. 6.5.2 Zhejiang Hisun Pharmaceutical Business Overview
  28. 6.5.3 Zhejiang Hisun Pharmaceutical Mercaptopurine Tablets Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Zhejiang Hisun Pharmaceutical Mercaptopurine Tablets Product Portfolio
  30. 6.5.5 Zhejiang Hisun Pharmaceutical Recent Developments
  31. 6.6 Guangzhou Baiyunshan Guanghua Pharmaceutical
  32. 6.6.1 Guangzhou Baiyunshan Guanghua Pharmaceutical Company Information
  33. 6.6.2 Guangzhou Baiyunshan Guanghua Pharmaceutical Business Overview
  34. 6.6.3 Guangzhou Baiyunshan Guanghua Pharmaceutical Mercaptopurine Tablets Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Guangzhou Baiyunshan Guanghua Pharmaceutical Mercaptopurine Tablets Product Portfolio
  36. 6.6.5 Guangzhou Baiyunshan Guanghua Pharmaceutical Recent Developments
  37. 6.7 Viatris
  38. 6.7.1 Viatris Company Information
  39. 6.7.2 Viatris Business Overview
  40. 6.7.3 Viatris Mercaptopurine Tablets Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Viatris Mercaptopurine Tablets Product Portfolio
  42. 6.7.5 Viatris Recent Developments
  43. 6.8 Stason Pharmaceuticals
  44. 6.8.1 Stason Pharmaceuticals Company Information
  45. 6.8.2 Stason Pharmaceuticals Business Overview
  46. 6.8.3 Stason Pharmaceuticals Mercaptopurine Tablets Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Stason Pharmaceuticals Mercaptopurine Tablets Product Portfolio
  48. 6.8.5 Stason Pharmaceuticals Recent Developments
  49. 6.9 Hikma Pharmaceuticals
  50. 6.9.1 Hikma Pharmaceuticals Company Information
  51. 6.9.2 Hikma Pharmaceuticals Business Overview
  52. 6.9.3 Hikma Pharmaceuticals Mercaptopurine Tablets Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Hikma Pharmaceuticals Mercaptopurine Tablets Product Portfolio
  54. 6.9.5 Hikma Pharmaceuticals Recent Developments
  55. 6.10 Dr. Reddy's Laboratories
  56. 6.10.1 Dr. Reddy's Laboratories Company Information
  57. 6.10.2 Dr. Reddy's Laboratories Business Overview
  58. 6.10.3 Dr. Reddy's Laboratories Mercaptopurine Tablets Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Dr. Reddy's Laboratories Mercaptopurine Tablets Product Portfolio
  60. 6.10.5 Dr. Reddy's Laboratories Recent Developments
7 North America by Country
  1. 7.1 North America Mercaptopurine Tablets Sales by Country
  2. 7.1.1 North America Mercaptopurine Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Mercaptopurine Tablets Sales by Country (2021-2026)
  4. 7.1.3 North America Mercaptopurine Tablets Sales Forecast by Country (2027-2032)
  5. 7.2 North America Mercaptopurine Tablets Market Size by Country
  6. 7.2.1 North America Mercaptopurine Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Mercaptopurine Tablets Market Size by Country (2021-2026)
  8. 7.2.3 North America Mercaptopurine Tablets Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Mercaptopurine Tablets Sales by Country
  2. 8.1.1 Europe Mercaptopurine Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Mercaptopurine Tablets Sales by Country (2021-2026)
  4. 8.1.3 Europe Mercaptopurine Tablets Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Mercaptopurine Tablets Market Size by Country
  6. 8.2.1 Europe Mercaptopurine Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Mercaptopurine Tablets Market Size by Country (2021-2026)
  8. 8.2.3 Europe Mercaptopurine Tablets Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Mercaptopurine Tablets Sales by Country
  2. 9.1.1 Asia-Pacific Mercaptopurine Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Mercaptopurine Tablets Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Mercaptopurine Tablets Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Mercaptopurine Tablets Market Size by Country
  6. 9.2.1 Asia-Pacific Mercaptopurine Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Mercaptopurine Tablets Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Mercaptopurine Tablets Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Mercaptopurine Tablets Sales by Country
  2. 10.1.1 South America Mercaptopurine Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Mercaptopurine Tablets Sales by Country (2021-2026)
  4. 10.1.3 South America Mercaptopurine Tablets Sales Forecast by Country (2027-2032)
  5. 10.2 South America Mercaptopurine Tablets Market Size by Country
  6. 10.2.1 South America Mercaptopurine Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Mercaptopurine Tablets Market Size by Country (2021-2026)
  8. 10.2.3 South America Mercaptopurine Tablets Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Mercaptopurine Tablets Sales by Country
  2. 11.1.1 Middle East and Africa Mercaptopurine Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Mercaptopurine Tablets Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Mercaptopurine Tablets Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Mercaptopurine Tablets Market Size by Country
  6. 11.2.1 Middle East and Africa Mercaptopurine Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Mercaptopurine Tablets Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Mercaptopurine Tablets Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Mercaptopurine Tablets Value Chain Analysis
  2. 12.1.1 Mercaptopurine Tablets Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Mercaptopurine Tablets Production Mode & Process
  7. 12.2 Mercaptopurine Tablets Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Mercaptopurine Tablets Distributors
  10. 12.2.3 Mercaptopurine Tablets Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst